JACC Asia - Coronary Physiology in the Catheterization Laboratory

Dr. Bon-kwon Koo is a professor of Seoul National University, director of cardiovascular center and chair in Cardiology Division of Seoul National University Hospital, Seoul, Korea. Dr. Koo graduated Yonsei University, Seoul, Korea and was a visiting scholar at Stanford University previously and worked with Professor Peter J Fitzgerald and Professor William Fearon. Dr. Koo is an interventional cardiologist and his main research interest is imaging and physiology of coronary artery disease. Dr. Koo is a principal investigator of many domestic and international studies. He has published more than 400 papers in major journals. He was a course director of TCT-AP and is a course co-director of ENCORE course. He has performed series of studies on bifurcation lesions and coronary physiology/imaging which provided important insights in this field. His recent researches on non-invasive hemodynamic assessment using coronary CT angiography and computational fluid dynamics enables the assessment of FFR without invasive procedures and has started a new chapter in the diagnosis of coronary artery disease. This innovation has now been expanded to non-invasive treatment planner and non-invasive assessment for the risk of ACS.

Chang-Wook Nam, M.D., Ph.D., is Professor, obtained his M.D. and Ph.D. degrees from Keimyung University, College of Medicine in Korea, where he subsequently did fellowship in cardiology. He undertook a postdoctoral research fellowship at Stanford University Medical Center. His research interests include invasive coronary physiology and imaging, coronary bifurcation lesion, analyses of vascular response and clinical outcomes with statin therapy. Prof. Nam has published more than 200 papers in peer-interviewed journals such as NEJM, JACC series, Circulation series, EHJ, Eurointervention and has served as invited reviewer in those journals. His work was awarded the Best publication prize by the Korean Society of Internal Medicine in 2019, 2014, and 2006. He serves as a member of the Academic Committee of the Korean Society of Cardiology, Vice president of Korean Bifurcation club, and an associate editor of the Korean Circulation Journal. He is also active as a member of many other Korean and international professional societies.

A hospital president at Zhejiang University School of Medicine, Hangzhou, China. Features in 5 videos on Wondr Medical. Jian’an Wang generally speaks on Covid-19, Trans Mitral Valve Implantation (TMVR), Mitral, and Coronary Physiology and Imaging.

A cardiologist at University of Ulsan, Ulsan, Namgu, South Korea. Features in 10 videos on Wondr Medical. Jung-Min Ahn generally speaks on Imaging, Left Main Stem (LMS), Bifurcation, Stable Coronary Artery Disease (CAD), and Transcatheter Aortic Valve Implantation (TAVR / TAVI).

Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.